福瑞股份:诺和诺德司美格鲁肽mash适应症FDA纳入优先审评 预计四季度上市

全景网
May 09, 2025

5月9日下午,福瑞股份(300049.SZ)2024年度业绩网上说明会在全景路演成功举办。会上,问及诺和诺德司美格鲁肽mash适应症FDA纳入优先审评,何时上市以及海外装机情况,福瑞股份董事会秘书孙秀珍表示,诺和诺德司美格鲁肽mash适应症FDA纳入优先审评,按正常节奏,预计四季度将会上市;目前公司海外装机按公司节奏在进行。(全景网)更多业绩说明会详情,请点击:https://rs.p5w.net...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10